title: PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas.
abstract: OBJECTIVE
  Loss of phosphatase and tensin homolog (PTEN) expression is common in ovarian clear cell adenocarcinomas (OCCA), but PTEN mutations are not frequently observed in OCCA. The mechanism of PTEN gene silencing in OCCA is still not clear.
  
  
  METHODS
  Immunohistochemical analysis of PTEN expression was performed in 40 OCCA paraffin-embedded tissues. PTEN promoter methylation in 24 OCCA tissues and 5 OCCA cell lines was examined by methylation-specific PCR. Eighteen OCCA patients and 13 serous adenocarcinomas were analyzed for loss of heterozygosity (LOH) at 10q23 with five polymorphic markers.
  
  
  RESULTS
  Of the 40 OCCAs, 37.5% (15/40) had reduced PTEN immunoreactivity, LOH was found in 33% (6/18) of OCCAs, and 31% (4/13) of serous adenocarcinomas. In the 33% of OCCAs with LOH, only 33% (2/6) lost PTEN expression. PTEN promoter was unmethylated in 5 OCCA cell lines and 24 OCCA tissues detected by MSP-PCR. No significant correlation between PTEN expression and advanced stage disease or overall survival was found.
  
  
  CONCLUSIONS
  Our results indicate that reduced PTEN expression was detected in more than one third of OCCA cases. Neither PTEN promoter methylation nor LOH at 10q23 locus is significantly related to PTEN inactivation and is not an adverse prognostic factor in OCCA.
authors.affiliation: Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan.
authors.forename: Chih-Ming
authors.initials: CM
authors.lastname: Ho
authors.forename: Ming-Chieh
authors.initials: MC
authors.lastname: Lin
authors.forename: Shih-Hung
authors.initials: SH
authors.lastname: Huang
authors.forename: Chi-Jung
authors.initials: CJ
authors.lastname: Huang
authors.forename: Hung-Cheng
authors.initials: HC
authors.lastname: Lai
authors.forename: Tsai-Yen
authors.initials: TY
authors.lastname: Chien
authors.forename: Shwu-Fen
authors.initials: SF
authors.lastname: Chang
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D000328:Adult; D000368:Aged; D002879:Chromosomes, Human, Pair 10; D018284:Cystadenocarcinoma, Serous / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D019175:DNA Methylation; D005260:Female; D020868:Gene Silencing; D006801:Humans; D007150:Immunohistochemistry; D019656:Loss of Heterozygosity; D008875:Middle Aged; D010048:Ovarian Cysts / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D010051:Ovarian Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D051059:PTEN Phosphohydrolase / Q000096:biosynthesis / Q000235:genetics*; D011401:Promoter Regions, Genetic; D015996:Survival Rate; D014407:Tumor Cells, Cultured
chemical_list: D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human